logo
University of York plans to open campus in India

University of York plans to open campus in India

BBC News04-05-2025
The University of York has announced plans to open a new campus in India.The institution said it had signed a memorandum of understanding with the Chief Minister of the state of Maharashtra to open the site in Mumbai.A spokesperson said it hoped to begin accepting students in time for the 2026/27 academic year.Vice-Chancellor of the University of York, Prof Charlie Jeffery, described the plan as "a really exciting venture" and a chance to contribute to the education of India's "future leaders and entrepreneurs".
A university spokesperson said the next step would be to receive a licence from the University Grants Commission in India to develop the campus.It would initially offer undergraduate and post-graduate courses in computer science, with AI and cyber security, business, economics and creative industries.
Prof Jeffery, who met with Indian Prime Minister Narendra Modi to discuss the plans, said: "We're working with a country that has an ambitious drive for global influence, skills development and economic growth."This is a really exciting venture and we are committed to building and strengthening our connections in India and contributing to the education of its future leaders and entrepreneurs."Studies are expected to begin in an existing building in a business quarter of Mumbai, with plans to develop a full campus complex over the coming years. A university spokesperson said students would study in India and follow the curriculum taught at its UK base, graduating with a University of York degree.Mr Fadnavis, said: "It is a privilege to welcome the University of York to Mumbai as we expand world-class educational opportunities in India."
Listen to highlights from North Yorkshire on BBC Sounds, catch up with the latest episode of Look North.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Cwmbran: Tandoorz takeaway awarded five-star hygiene rating
Cwmbran: Tandoorz takeaway awarded five-star hygiene rating

South Wales Argus

timea day ago

  • South Wales Argus

Cwmbran: Tandoorz takeaway awarded five-star hygiene rating

Tandoorz, located in Fairwater Square, opened on June 5 and was inspected on June 25. The takeaway, which serves kebabs, wraps, curries, and Indian-flavoured pizzas, was rated as "good" in both hygienic food handling and cleanliness and condition of facilities and building. In their management of food safety, they received a "very good" rating. A spokesperson for Tandoorz said: "We had our first visit from Torfaen environmental health, and we are delighted to have achieved a five-star rating. "Many thanks to all our already growing loyal customers for your support, and great thanks to the Tandoorz team. "Our kitchen is open plan, so everyone is welcome to come and see their meals being cooked fresh in front of them by our skilled chefs. "We also have lots of collection-only deals." Tandoorz offer a variety of dishes including donner kebabs in plain, tandoori, or naga flavours, and chicken tikka kebabs made from fresh marinated chicken breast cooked on the chargrill. All their kebabs and wraps are served using fresh naan cooked in the tandoor oven. They also offer traditional curries and Indian-flavoured pizzas. Customers have the option to order online at where they can get 10 per cent off and collect loyalty points. The food hygiene rating is based on three areas: hygienic food handling, cleanliness and condition of facilities and building, and management of food safety. The rating ranges from 0, which means urgent improvement is required, to 5, which means hygiene standards are very good. The inspection is carried out by officers from the food safety team at the council.

UK-India trade deal sparks fears over access to cheap medicines for millions
UK-India trade deal sparks fears over access to cheap medicines for millions

ITV News

timea day ago

  • ITV News

UK-India trade deal sparks fears over access to cheap medicines for millions

A newly signed trade agreement between India and the UK has triggered concerns that millions of poor Indians may lose access to affordable life-saving medicines. Civil society groups and health experts say the UK-India Free Trade Agreement (FTA), finalised between two countries, tilts the balance in favour of multinational pharmaceutical corporations and threatens to erode long-standing protections that have allowed India to produce low-cost generic drugs. 'This is not just about trade. It's about whether a person living on ₹200 (£2) a day can afford cancer treatment or survive tuberculosis,' said Jyotsna Singh, co-convenor of the Working Group on Access to Medicines and Treatments. At the heart of the controversy are the agreement's intellectual property (IP) provisions, which activists say may restrict the Indian government's ability to issue compulsory licences—legal tools that allow domestic companies to manufacture patented drugs at reduced prices during public health emergencies. India used this provision in 2012 to dramatically cut the price of sorafenib, a cancer drug sold by Bayer under the brand Nexavar. Generic versions slashed the monthly cost by nearly 97%, from ₹2.8 lakh (£2,600) to around ₹8,800 (£80), making it affordable to thousands. 'By discouraging compulsory licensing and promoting voluntary licences, the deal hands over control of access to medicines to the market,' said Prof Biswajit Dhar, a trade expert and former professor at New Delhi's Jawaharlal Nehru University. 'Voluntary licences often come with strings attached and don't bring the same price reductions.' Weakening India's Patent Safeguards Under the FTA, companies will no longer need to report annually how their patents are being 'worked'—or used—in India. Instead, disclosures can be made every three years, and some information can be kept confidential. Activists say this undermines transparency and makes it harder to prove that a drug isn't available to the public, a key step in applying for a compulsory licence. There are also concerns the deal could open the door to 'evergreening'—a tactic in which companies make minor changes to existing drugs and claim new patents. Indian law currently limits this practice under Section 3(d) of the Patents Act, but experts warn the FTA's emphasis on 'harmonisation' of IP standards with Western countries could override such protections. 'This is effectively a backdoor entry for TRIPS-plus provisions,' said K.M. Gopakumar, co-convenor of the Working Group. 'It would push India to grant unnecessary patents, prolonging monopolies and delaying cheaper alternatives.' The Indian pharmaceutical industry supplies more than 60% of global vaccines and a significant share of affordable generics to low- and middle-income countries. Critics say the FTA may limit this capacity and ultimately have consequences well beyond India's borders. Government response The Indian government has promoted the FTA as a landmark deal that will boost exports and attract UK investment in manufacturing, services, and digital trade. Officials insist that India has preserved its ability to protect public health. But rights groups remain unconvinced. 'You cannot negotiate away access to life-saving drugs in the name of free trade,' said Gargeya Telakapalli, a public health campaigner based in Hyderabad. 'The poorest Indians—those with cancer, HIV, diabetes, or TB—are being quietly sacrificed.' Broader implications The deal follows a similar agreement India signed last year with the European Free Trade Association (EFTA), which also faced criticism for diluting IP safeguards. Observers say the trend may reflect a shift in India's trade policy as it seeks closer ties with Western economies. But for many in India's healthcare and legal communities, the question remains: how much access to medicine is the country willing to give up for a better trade balance? From Westminster to Washington DC - our political experts are across all the latest key talking points. Listen to the latest episode below...

Martin Lewis's top items to buy cheaper on holidays abroad
Martin Lewis's top items to buy cheaper on holidays abroad

The Independent

time2 days ago

  • The Independent

Martin Lewis's top items to buy cheaper on holidays abroad

has shared tips on which items you should buy overseas for a cheaper price as the summer holidays approach. Speaking on his BBC Sounds podcast on Sunday's (11 May) episode, the Money Saving Expert founder revealed which common items holidaymakers can bring back for a much cheaper price than they are in the UK. Lewis shared a submission from one of his listeners, who said they bought bottles of wine from Spain for almost £100 cheaper than they are sold for in a UK supermarket.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store